このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Interactive Robot-Guided Exercise Program for Cancer-Related Fatigue

2026年9月9日 更新者:Tsai-Wei Huang、Taipei Medical University

Using an Interactive Kebbi Robot to Develop an Exercise Program for Cancer-Related Fatigue: Assessing Its Effectiveness

The goal of this study is to learn whether an exercise program guided by an interactive robot can help reduce tiredness in people with cancer. This kind of tiredness, called cancer-related fatigue, is common during cancer treatment and can make everyday activities harder.

People who take part in the exercise program will do sessions guided by the robot. Before and after each session, the study team checks things like heart rate, breathing rate, and blood pressure, and asks about tiredness and other symptoms.

Family members and nurses who help patients use the robot are also asked to share their views on how well the robot's teaching materials hold their attention and help them feel confident and satisfied.

Everyone who joins the exercise part of the study receives the same robot-guided program. There is no separate group that skips the robot program.

調査の概要

詳細な説明

Cancer-related fatigue is one of the most common and distressing symptoms experienced by patients undergoing cancer treatment, often persisting despite rest and negatively affecting daily function and quality of life. Exercise is a recommended non-pharmacological strategy to help manage this symptom, but adherence to conventional exercise programs among cancer patients is often limited.

This study develops and evaluates an exercise teaching program delivered through an interactive robot (Kebbi) for cancer patients treated at Taipei Medical University-affiliated Wanfang Hospital. The robot guides participants through a structured exercise routine. Physiological parameters (heart rate, respiratory rate, systolic and diastolic blood pressure) are recorded immediately before and after exercise sessions, and patient-reported fatigue and symptom burden are assessed repeatedly over the course of the intervention period.

In addition to the patient cohort, family caregivers and nursing staff who interact with the robot-based teaching materials are invited to evaluate the instructional design of the materials, focusing on their ability to engage attention, demonstrate relevance, build confidence, and achieve satisfaction.

This is a single-group study; all enrolled patients receive the robot-guided exercise program, and outcomes are compared within participants before versus after the intervention. No randomization or control group is used.

研究の種類

介入

入学 (実際)

46

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Taipei、台湾
        • Wanfang Hospital

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age 20 years or older
  • Confirmed diagnosis of cancer, currently receiving anticancer treatment at Taipei Municipal Wanfang Hospital
  • Presence of cancer-related fatigue (self-reported or clinically assessed)
  • Sufficient cognitive and physical function to participate in a robot-guided, low-to-moderate intensity exercise program
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Severe cognitive impairment or communication barriers preventing comprehension of study instructions
  • Unstable cardiopulmonary or hemodynamic status contraindicating exercise
  • Bedridden or physical performance status precluding participation in basic exercise movements

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Robot-Guided Exercise Group
Cancer patients receiving the interactive robot (Kebbi)-guided exercise program. Vital signs, fatigue, and symptom burden are assessed before and after sessions.
A structured exercise program delivered and guided by an interactive robot (Kebbi), designed to help manage cancer-related fatigue.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Cancer-Related Fatigue Severity
時間枠:Baseline (prior to intervention) through completion of the intervention (up to 5 days), assessed up to three times daily during the intervention period
Fatigue severity assessed using the Brief Fatigue Inventory (BFI), a self-reported measure with items rated from 0 (no fatigue) to 10 (fatigue as bad as you can imagine). Higher scores indicate greater fatigue severity.
Baseline (prior to intervention) through completion of the intervention (up to 5 days), assessed up to three times daily during the intervention period

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Symptom Burden
時間枠:Baseline (prior to intervention) and immediately after completion of the intervention (up to 5 days)
Symptom burden assessed using the Edmonton Symptom Assessment Scale (ESAS), which rates the severity of multiple symptoms (e.g., pain, tiredness, drowsiness, nausea, appetite) on a 0-10 scale. Higher scores indicate greater symptom severity.
Baseline (prior to intervention) and immediately after completion of the intervention (up to 5 days)
Change in Heart Rate
時間枠:Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Heart rate (beats per minute) measured immediately before and immediately after each exercise session.
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Change in Respiratory Rate
時間枠:Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Respiratory rate (breaths per minute) measured immediately before and immediately after each exercise session.
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Change in Systolic Blood Pressure
時間枠:Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Systolic blood pressure (mmHg) measured immediately before and immediately after each exercise session.
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Change in Diastolic Blood Pressure
時間枠:Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
Diastolic blood pressure (mmHg) measured immediately before and immediately after each exercise session.
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年8月13日

一次修了 (実際)

2025年9月10日

研究の完了 (実際)

2025年9月10日

試験登録日

最初に提出

2026年7月4日

QC基準を満たした最初の提出物

2026年9月9日

最初の投稿 (実際)

2026年9月15日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月15日

QC基準を満たした最後の更新が送信されました

2026年9月9日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • ROBOT_education_N202407020
  • TMU-JIRB (その他の識別子:TMU-JIRB)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する